Pallasch T J
Pharmacology Section, USC School of Dentistry, Los Angeles, CA 90089.
J Calif Dent Assoc. 1993 Feb;21(2):34-44.
By virtue of their activity against common and microbial pathogens, three antibiotic groups have real or potential application in the routine management of acute orofacial infections: beta-lactams (penicillins and cephalosporins), macrolides (erythromycin and congeners) and the lincosamides (clindamycin). The beta-lactam agents, principally the penicillins, remain drugs of choice. The macrolides have gained a resurgence in popularity due to their low toxicity, improved pharmacokinetics with azithromycin and clarithromycin, and the ability to penetrate into white blood cells to attack intracellular microorganisms. Clindamycin may be useful in penicillin-allergic patients and when directed by culture and sensitivity tests.
由于对常见和微生物病原体具有活性,三类抗生素在急性口腔面部感染的常规治疗中具有实际或潜在应用:β-内酰胺类(青霉素和头孢菌素)、大环内酯类(红霉素及其同类物)和林可酰胺类(克林霉素)。β-内酰胺类药物,主要是青霉素,仍然是首选药物。大环内酯类药物因毒性低、阿奇霉素和克拉霉素的药代动力学有所改善以及能够穿透白细胞以攻击细胞内微生物而再度受到欢迎。克林霉素可能对青霉素过敏患者有用,也可根据培养和药敏试验使用。